Economic Evaluation alongside a Phase II, Multi-Centre, Randomised Controlled Trial of Very Early Rehabilitation after Stroke (AVERT)
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background/Purpose: The effectiveness and costs of very early rehabilitation after stroke are unknown. This study assessed the cost effectiveness of very early mobilisation in addition to standard care (VEM) compared with standard care alone (SC). Methods: Cost-effectiveness analysis alongside a phase II, multi-centre, randomised controlled trial (RCT) with blinded outcome assessments. Less than 24 h after stroke, patients were recruited from two stroke units and randomised to receive VEM or SC. The intervention continued until discharge or 14 days, whichever was sooner. The efficacy measure was a dichotomised modified Rankin Scale (mRS) at 3 months with mRS ≤2 representing good outcome. Costs were determined from medical records and patient interviews at 3, 6 and 12 months. National average (where available) or local costs were applied for the reference year 2004. Differences in mean total costs at 3 and 12 months were tested using t test assuming unequal variances. An incremental cost-effectiveness ratio was calculated and probabilistic uncertainty analysis was undertaken. Results: The sample consisted of 38 VEM and 33 SC patients. A trend for good outcome with VEM compared to SC was found (adjusted OR 4.10, 95% CI 0.99–16.88, p = 0.051). Patients receiving VEM incurred significantly less costs at 3 months (AUD 13,559) compared with SC (AUD 21,860; p = 0.02). This difference in mean per patient total cost persisted at the 12-month assessment (VEM: AUD 17,564; SC: AUD 29,750; p = 0.03). VEM was found to be a ‘dominant’ (more effective, less cost) intervention when compared to SC at 3 months. Conclusion: These findings provide preliminary evidence that VEM is likely to be cost-effective. A large RCT is currently underway to confirm the cost effectiveness of VEM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The phase 2 study of AVERT provided preliminary evidence that very early mobilisation started within 24 h of stroke onset and continued frequently thereafter was feasible, likely to be safe 12 with promising improvements in walking recovery, 13 and could be cost effective. 14”
From Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial (2015) · cites this paper as [14]
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Banks, J. L., & Marotta, C. A. (2007) · Stroke · doi:10.1161/01.str.0000258355.23810.c6 · Cited by 2,253 · cited 1×
“Ethics committees approved the study and informed consent was obtained. Efficacy The sample size was calculated according to the primary safety outcome of the phase II trial, i.e. death at 3 months. The modified Rankin Scale (mRS) [ ,”
MethodThe burden of disease and injury in Australia 2003
Begg, S. J., Vos, T., Barker, B. M., Stevenson, C., Stanley, L., & López, A. D. (2007) · Deakin Research Online (Deakin University) · Cited by 1,285
Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720 · cited 1×
“An annual discount rate of 3p was applied where appropriate. A listing of all unit costs used can be found in online supplement table 1 (www.karger.com/doi/10.1159/ 000155984). Data Analysis Consistent with the analysis for efficacy, 3 months was the primary assessment time point for this evaluation. Nonetheless, reso…”
MethodInfluentialTreatment in a Combined Acute and Rehabilitation Stroke Unit: Which Aspects Are Most Important?
Indredavik, B., Bakke, F., Slørdahl, S. A., Rokseth, R., & Håheim, L. L. (1999) · Stroke · doi:10.1161/01.str.30.5.917 · Cited by 368
A Very Early Rehabilitation Trial for Stroke (AVERT): Phase II Safety and Feasibility
Bernhardt, J., Dewey, H., Thrift, A., Collier, J., & Donnan, G. (2008) · Stroke · doi:10.1161/strokeaha.107.492363 · Cited by 366 · cited 1×
“This intervention has the potential to benefit a large proportion of stroke patients who are suitable for early rehabilitation. The findings from a phase II, multi-centre, randomised controlled trial, A Very Early Rehabilitation Trial for Stroke (AVERT), provide evidence for the safety and feasibility of very early mo…”
BackgroundSelf-citationDewey, H. M., Thrift, A. G., Mihalopoulos, C., Carter, R., Macdonell, R. A. L., McNeil, J. J., & Donnan, G. A. (2001) · Stroke · doi:10.1161/hs1001.097222 · Cited by 184 · cited 1×
“From the viewpoint of decision-makers who are faced with scarce resources, the economic justification for implementing VEM is equally important as evidence for efficacy. The intervention’s cost-effectiveness credentials are especially relevant given the significant disease and economic burden associated with stroke [ ,”
BackgroundSelf-citationDewey, H. M., Thrift, A. G., Mihalopoulos, C., Carter, R., Macdonell, R. A. L., McNeil, J. J., & Donnan, G. A. (2002) · Stroke · doi:10.1161/01.str.0000013067.24300.b0 · Cited by 181 · cited 1×
“When productivity losses were included in the total cost estimates, the cost differences between groups were increased (but with much greater variance) because all 3 patients who had productivity loss following stroke were randomised to the SC group. Given the small sample, this finding should be interpreted with caut…”
Self-citationO’Sullivan, A. K., Thompson, D., & Drummond, M. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.03065.x · Cited by 108
Early Mobilisation after Stroke: Review of the Literature
Diserens, K., Michel, P., & Bogousslavsky, J. (2006) · Cerebrovascular Diseases · doi:10.1159/000093453 · Cited by 89
Very Early Versus Delayed Mobilization After Stroke
Bernhardt, J. A., Thuy, M. N. T., Collier, J. M., & Legg, L. A. (2009) · Stroke · doi:10.1161/strokeaha.109.549899 · Cited by 48
Self-citationMobilisation ‘in Bed’ Is Not Mobilisation
Bernhardt, J. A., Indredavik, B., Dewey, H. M., Langhorne, P., Lindley, R. I., Donnan, G. A., Thrift, A. G., & Collier, J. M. (2007) · Cerebrovascular Diseases · doi:10.1159/000103626 · Cited by 30
Self-citationThe Role of Pilot Studies in the Economic Evaluation of Health Technologies
Drummond, M., & Coyle, D. (1998) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300011399 · Cited by 22 · cited 1×
“These include stronger internal validity and the timeliness of collecting patient-level economic data. The value of conducting an economic evaluation for a pilot study has also been recognised [”
BackgroundBernhardt, J. A., Dewey, H., Donnan, G. A., Thrift, A. G., Lindley, R. I., & Moodie, M. (2007) · Deakin Research Online (Deakin University) · Cited by 8
Self-citation
Cited by
(2015) · The Lancet · doi:10.1016/s0140-6736(15)60690-0 · Cited by 789
Economic burden of stroke: a systematic review on post-stroke care
Rajsic, S., Gothe, H., Borba, H. H., Sroczynski, G., Vujicic, J., Toell, T., & Siebert, U. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-018-0984-0 · Cited by 470
Outcomes of inpatient mobilization: a literature review
Kalisch, B. J., Lee, S., & Dabney, B. W. (2014) · Journal of Clinical Nursing · doi:10.1111/jocn.12315 · Cited by 213
Langhorne, P., Wu, O., Rodgers, H., Ashburn, A., & Bernhardt, J. (2017) · Health Technology Assessment · doi:10.3310/hta21540 · Cited by 186
“Features Patients (N= 2104) Recruitment region, n (%) Australia/New Zealand 1243 (59) Asia 251 (12) UK 610 (29) Patient characteristics Age (years), median (IQR) 73 (63–80) Female, n (%) 818 (40) Risk factors, n (%) Hypertension 1424 (68) Ischaemic heart disease 487 (23) Hypercholesterolaemia 929 (40) Diabetes mellitu…”
BackgroundSelf-citationAustin, M. W., Ploughman, M., Glynn, L., & Corbett, D. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.06.007 · Cited by 153
Metadata
- Authors
- Tay-Teo, K., Moodie, M., Bernhardt, J., Thrift, A. G., Collier, J., Donnan, G., & Dewey, H.
- Affiliations
- The University of Melbourne (AU)
- Deakin University (AU)
- The Alfred Hospital (AU)
- Florey Institute of Neuroscience and Mental Health (AU)
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 26
- Issue
- 5
- Pages
- 475-481
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W2048025423
- Cited by
- 67
- References
- 15
- Citations by year
- 2024: 12 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cerebrovascular Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- stroke, early rehabilitation, cost-effectiveness, modified Rankin Scale, stroke recovery, health care costs
- MeSH terms
- Stroke Rehabilitation, Aged, Australia, Cost-Benefit Analysis, Early Ambulation, Female, Health Services, Humans, Male, Middle Aged, Time Factors, Odds Ratio, Treatment Outcome, Cost Savings, Health Care Costs, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.